Helen Torley
CIK 1528185 · PRESIDENT AND CEO · last filed 2026-06-03
Helen Torley is a PRESIDENT AND CEO who has filed 116 SEC Form 4 insider transactions across 4 companies since 2011. The most recent filing, for HTI, was dated Jun 3, 2026. Across all open-market trades the lifetime net is −$87.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.27M
4
116
-$87.67M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HTI | PRESIDENT AND CEO | 767,780 | — | — | -$83.25M | 89 | 2026-06-03 |
| DGX | Director | 6,260 | $203.06 | $1.27M | $0 | 7 | 2021-05-25 |
| Relypsa Inc (RLYP) Delisted | Director | 0 | — | — | -$19.6K | 5 | 2016-09-02 |
| ONYX PHARMACEUTICALS INC (ONXX) Delisted | EVP, Chief Commercial Officer | 35,911 | — | — | -$4.40M | 14 | 2013-09-05 |
Recent Filings
116 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | HTI | Mixed | — | -$2.77M | EDGAR |
| 2026-05-13 | HTI | Mixed | — | -$2.83M | EDGAR |
| 2026-04-07 | HTI | Mixed | — | -$514.3K | EDGAR |
| 2026-04-02 | HTI | Mixed | — | -$2.11M | EDGAR |
| 2026-03-04 | HTI | Mixed | — | -$2.87M | EDGAR |
| 2026-02-24 | HTI | Mixed | +18,049 | -$1.50M | EDGAR |
| 2026-02-17 | HTI | Mixed | +41,012 | -$3.82M | EDGAR |
| 2026-02-11 | HTI | Grant (A) | — | $0 | EDGAR |
| 2026-02-05 | HTI | Mixed | — | -$3.25M | EDGAR |
| 2025-12-11 | HTI | Grant (A) | — | $0 | EDGAR |